Associated Medical Professionals of NY (A.M.P.) is pleased to announce that Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) has joined its care team. Specialty trained in urologic oncology and robotics, Dr. Stephenson has vast experience in diagnosing and treating urologic cancers using the latest minimally invasive technologies and more conventional approaches. Dr. Stephenson has performed more than 2,000 robotic urology surgeries in his career.
Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital.
Christopher M. Pieczonka, MD, Chief Executive Officer of Associated Medical Professionals of NY and Corporate Director of Clinical Research of U.S. Urology Partners, stated, “A.M.P. is very proud to have Dr. Andrew Stephenson join our practice. We are so excited to welcome a world renown expert and former Director of Urologic Oncology at the Cleveland Clinic to enhance and elevate the care of our local cancer patients. We look forward to the new skills and expertise that Dr. Stephenson will contribute that will put us on par with National Cancer Institute designated cancer centers.”
Dr. Andrew Stephenson said, “I am committed to excellence in patient care, research and innovations in urology. I am excited to join the team at A.M.P. as it provides me an opportunity to deliver innovative, compassionate and high-quality care to patients with complex urological problems, including cancers of the prostate, bladder, kidney and testis, BPH and prostate problems, and PSA screening. I am honored to join a team of like-minded and skilled professionals who are aligned in A.M.P.’s goals: to deliver world-class and comprehensive urological care to the people of the Syracuse community and upstate New York.”
“I am passionate about urological problems and the care of my patients. I endeavor to be my best every day for my patients. I have an unwavering commitment to developing and adopting the most effective treatments for my patients and advancing the field for future patients through clinical trials,” said Dr. Stephenson. “The state-of-the-art facilities at A.M.P. will enable me to deliver the most advanced and innovative urological care for my patients. We endeavor to be at the forefront of urological care, offering patients the spectrum of medical and surgical treatment for their urological problems.”
To learn more about Dr. Stephenson and A.M.P. or to schedule an appointment, please visit www.ampofny.com, www.ampofny.com/physicians/andrew-j-stephenson-md/ or call (315) 478-4185.
About Dr. Andrew J. Stephenson
Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) is an internationally recognized urologist, robotic surgeon and researcher. Before joining Associated Medical Professionals of NY, he served as Director of Urologic Oncology at Rush University Medical Center, Director of the Center of Urologic Oncology at Cleveland Clinic’s Glickman Urological and Kidney Institute and a staff member of the Taussig Cancer Institute. His clinical and research focus is on the treatment of patients with cancers of prostate, bladder and testis. He has published over 125 articles in peer-reviewed journals since 2002 on issues related to prostate, bladder and testis cancer, many of which have received international mainstream media attention. He has been invited to speak on these subjects at major international medical conferences.
Dr. Stephenson is board-certified in urology by the American Board of Urology and the Royal College of Physicians and Surgeons of Canada. He has received several awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology and Society of Urologic Oncology. He is listed as one of the Best Doctors in America. He received the Urology Teacher of the Year award while at Rush University and Cleveland Clinic.
Dr. Stephenson has received grant support for prostate cancer research from the Robert Wood Johnson Foundation. His research focus is on the development of prognostic statistical models called nomograms. These prognostic models provide accurate predictions of treatment outcome for prostate cancer and are widely used for patient counseling. He is on the editorial board for several urology journals, including Urology, and is an ad hoc reviewer for Journal of the National Cancer Institute, Journal of Clinical Oncology and Journal of Urology.
For patients with prostate cancer, Dr. Stephenson performs both nerve-sparing robotic prostatectomy using latest state-of-art approaches. The decision to perform either robotic or open prostatectomy is tailored to the specifics of each patient’s cancer and preferences. For patients with bladder cancer, Dr. Stephenson also performs robotic nerve-sparing radical cystectomy and orthotopic urinary diversion (neobladder or Studer) for both men and women. He is highly skilled on minimally invasive robotic approaches for kidney tumors and advanced kidney cancers. For select patients with testicular cancer, Dr. Stephenson performs robotic nerve-sparing lymph node dissection. He also has vast experience in minimally invasive treatments for BPH and voiding dysfunction. He has also been a pioneer in the development of biomarkers and image-guided diagnostic approaches for prostate cancer diagnosis and treatment.
About Associated Medical Professionals of NY (A.M.P.)
Associated Medical Professionals of New York (A.M.P.) is a multi-specialty medical practice based in Syracuse serving the Central New York region. Established in 2008, A.M.P. has grown to become one of the largest multi-specialty groups of its kind in the area that strives to provide quality care at each of its ten offices and nine hospital locations. As a pivotal point of care in each community, A.M.P. is able to provide continuity of care for a vast population of patients. A.M.P. maintains a robust suite of services, including advanced urological care, robotic surgery, cancer care, radiation oncology, pathology, lithotripsy, imaging and clinical research. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.ampofny.com and www.us-uro.com.